| Lung cancer treatment advances in 2022 F Abu Rous, EK Singhi, A Sridhar, MS Faisal, A Desai Cancer investigation 41 (1), 12-24, 2023 | 23 | 2023 |
| Chylothorax: complication attributed to dasatinib use A Al-Abcha, MH Iftikhar, FA Rous, H Laird-Fick BMJ Case Reports CP 12 (12), e231653, 2019 | 14 | 2019 |
| Breast cancer in geriatric patients: current landscape and future prospects H Abdel-Razeq, F Abu Rous, F Abuhijla, N Abdel-Razeq, S Edaily Clinical Interventions in Aging, 1445-1460, 2022 | 11 | 2022 |
| Pembrolizumab in combination with chemotherapy in patients with ERBB2-mutated non-small cell lung cancer F Abu Rous, R Gutta, P Li, B Halmos, S Gadgeel Targeted Oncology 17 (2), 187-192, 2022 | 5 | 2022 |
| When thyroid labs do not add up, physicians should ask patients about biotin supplements MS Lundin, A Alratroot, FA Rous, S Aldasouqi BMJ Case Reports CP 13 (3), e231337, 2020 | 4 | 2020 |
| Challenges faced by J-1 international medical graduates (IMGS) during Covid-19 pandemic F Abu Rous, I Riano Cancer investigation 41 (3), 249-252, 2023 | 3 | 2023 |
| Abiraterone acetate for treatment of ectopic Cushing syndrome caused by ACTH-producing neuroendocrine tumor: a case report R Chacko, NH Abdel-Razeq, FA Rous, R Loutfi Journal of Gastrointestinal Oncology 13 (5), 2626, 2022 | 2 | 2022 |
| Antithrombin supplementation in adults with acute lymphoblastic leukemia (ALL) following asparaginase therapy: a meta-analysis O Mosalem, M Mujer, FA Rous, CE Cole Blood 136, 20, 2020 | 2 | 2020 |
| Pulmonary embolism as the primary presentation of IgA vasculitis O Mosalem, NH Garcilazo, Y Saleh, FA Rous BMJ Case Reports CP 13 (8), e235884, 2020 | 2 | 2020 |
| Profiling changes in metabolism and the immune microenvironment in lung tumorigenesis D Zhang, AS Leal, FA Rous, KT Liby Annals of Translational Medicine 7 (Suppl 3), 2019 | 2 | 2019 |
| Emerging biomarkers in immune oncology to guide lung cancer management H Safa, F Abu Rous, N Belani, H Borghaei, S Gadgeel, B Halmos Targeted Oncology 18 (1), 25-49, 2023 | 1 | 2023 |
| Pyomyositis as an unusual presentation of colonic adenocarcinoma O Mosalem, FA Rous, A Al-Abcha, S Kherallah, J Burch The Permanente Journal 25, 2021 | 1 | 2021 |
| Diffuse Alveolar Hemorrhage Secondary to Direct Oral Anticoagulants: A Systematic Review of Reported Cases F Abu Rous, A al-Abcha, L El-Khatib, S Shrotriya, P Dhakal Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 1 | 2018 |
| ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report LF Gonzalez-Mosquera, FA Rous, A Rogers, N Smith, G Goyert, ... Clinical Lung Cancer 25 (2), e77-e80, 2024 | | 2024 |
| 104P A comprehensive analysis of the molecular landscape of HER3 expression in adenocarcinoma of the lung SK Alhushki, AN Al-Bzour, NN Al-Bzour, HM Abushukair, FA Rous ESMO Open 9, 2024 | | 2024 |
| Clinical Trials for Patients With Cancer FA Rous, A Desai, EK Singhi JAMA oncology, 2024 | | 2024 |
| OA10. 03 Assessing Availability and Demand for Patient-Friendly Resources in Lung Cancer Care: The Patient Perspective EK Singhi, A Desai, FA Rous, J Feldman Journal of Thoracic Oncology 18 (11), S65-S66, 2023 | | 2023 |
| 524 The association between mesothelial membranes metastasis and response to immune checkpoint inhibitors in solid tumors H Abushukair, C Logothetis, FA Rous, A Saeed, O Aranha Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| P2. 09-39 Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers R Gutta, FA Rous, E Teslow, E Jaeger, S Gadgeel, B Potugari Journal of Thoracic Oncology 18 (11), S349, 2023 | | 2023 |
| Prognostic relevance of 3q amplification (AMP) in a racially diverse patient population with advanced squamous cell carcinoma of the lung. F Abu Rous, P Li, S Carskadon, R Gutta, BR Potugari, SM Gadgeel, ... Journal of Clinical Oncology 41 (16_suppl), e15142-e15142, 2023 | | 2023 |
Osama MosalemMayo clinic在 mayo.edu 的电子邮件经过验证
